Drug resistance and activity changes of thioredoxin reductase in pancreatic cancer cells strain SW1990 induced by gemcitabine / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 606-610, 2005.
Artículo
en Chino
| WPRIM
| ID: wpr-318854
ABSTRACT
<p><b>OBJECTIVE</b>To establish gemcitabine-resistant pancreatic cancer cell strain and study the role of thioredoxin reductase (TrxR) in drug-resistant process.</p><p><b>METHODS</b>Gemcitabine-resistant pancreatic cancer cell strain SW1990/GZ was induced by increasing drug dosage intermittently, then the changes of its biological features and the activity of TrxR were examined.</p><p><b>RESULTS</b>Stable drug-resistant SW1990/GZ cell strain was established by culturing with gemcitabine for 9 months. The morphology and growth characteristics of the cell strain changed remarkably. The cells shrunk and became rounder; its endoplasm expanded; granular substances increased; and the doubling-time was prolonged. Resistance of the cell line to gemcitabine, fluorouracil, adriamycin, and mitomycin significantly increased. The TrxR activity of the drug-resistant cells was increased markedly.</p><p><b>CONCLUSION</b>SW1990/GZ has certain multidrug resistance to some chemotherapy drugs, and TrxR plays a role in the drug-resistant process.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Neoplasias Pancreáticas
/
Patología
/
Farmacología
/
Reductasa de Tiorredoxina-Disulfuro
/
Resistencia a Antineoplásicos
/
Línea Celular Tumoral
/
Desoxicitidina
/
Metabolismo
/
Antimetabolitos Antineoplásicos
Límite:
Humanos
Idioma:
Chino
Revista:
Acta Academiae Medicinae Sinicae
Año:
2005
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS